SRF funded-investigator Dr. Howard Chang of the Stanford University School of Medicine is working on an innovative project to understand disease-relevant mechanisms in scleroderma: his novel Twin Study is investigating differences in genetically identical twins where one twin has scleroderma and...
Read More
SAN FRANCISCO (May 9, 2022) – The Scleroderma Research Foundation (SRF) will host its inaugural Virtual Patient Forum, Collaborating for a Cure, on Wednesday, June 1, 2022, to kick off...
Read More
Meet Sarah Wood, the Clinical/Translational Research Coordinator at Vanderbilt University Medical Center. A recently graduated master's student who researched autoimmune diseases, she's now turning her focus to ending scleroderma. She...
Read More
In 2018, the SRF launched CONQUER (COllaborative, National Quality and Efficacy Registry), a first-of-its-kind nationwide, longitudinal registry of scleroderma patients. For those who live with scleroderma, participating in CONQUER is...
Read More
As we say hello to March, we're sharing this month's edition of eNews. Highlights include: ➡️ How two of Bob Saget's friends honor his dedication to ending scleroderma ➡️ Which...
Read More
Research is the best hope for finding a cure. This is why in 2018, the SRF launched CONQUER (COllaborative, National QUality and Efficacy Registry), a first-of-its-kind nationwide, longitudinal registry of...
Read More
The SRF launched the CONQUER Registry in 2018 through a collaborative effort with the largest scleroderma centers in the U.S. The goal of this registry is the enrollment of thousands...
Read More
Rae is a medical researcher, a self-described nurturer and dreamer–and someone who lives with scleroderma. In our conversation with her, Rae talks about her journey to being diagnosed, how it...
Read More
Participating in research is crucial to finding a cure for scleroderma. SRF Cure Crew member Melissa talks about just this in a new 23andMe blog post. She participated in 23andMe's...
Read More
